Skip to main content

Table 1 Patient characteristics at baseline

From: Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study

Variable

n = 11

Age (years)

58 (33–79)

Sex (males/females)

8/3

Body mass index (kg/m2)

24.9 ± 3.6

Subjective global assessment score (A/B)

5/6

Hemodialysis vintage (months)

35 (11–232)

Dialysis days per week (2/3/4 days)

1/8/2

Urine production ≥ 200 mL/day (yes/no)

4/7

Kt/V

1.58 ± 0.38

Normalized nitrogen protein appearance rate (nPNA) (g/kg/day)

0.91 ± 0.16

Plasma albumin (g/L)

38.8 ± 2.1

pH

7.43 ± 0.03

S-HCO3- (mmol/L)

25.5 ± 2.0

Blood glucose (mmol/L)

5.2 ± 0.4

Serum insulin (pmol/L)

33.9 ± 19.1

Serum bioactive IGF-I (μg/L)

0.83 ± 0.27

Serum total IGF-I (μg/L)

124 ± 43

Serum IGFBP-1 (μg/L)

267 ± 147

Serum IGFBP-2 (μg/L)

1949 ± 1112

  1. Data are mean ± SD, median (range), or number.
  2. At baseline no differences were observed in biomarker concentrations between study days and overall mean concentrations are shown.